After-hours movers: Apple, Amazon, and Google all fall as results disappoint
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Google releases new AI 'Bard' to testers ahead of public release
February 6, 2023 2:49 PM ESTGoogles parent company, Alphabet Inc, (NASDAQ: GOOG) announced in a blog post on Monday that the company is planning to launch a chatbot service called Bard. Bard is powered by LaMDA, Google's AI that can generate human-like prose. The technology company opened the conversational AI service to test users for feedback, and will be followed by a public release in the coming... More
Evercore ISI Removes Apple (AAPL) From Tactical Outperform List
February 3, 2023 11:30 AM ESTEvercore ISI analyst Amit Daryanani reiterated an Outperform rating and $190.00 price target on Apple (NASDAQ: AAPL)
The analyst comments "We are removing AAPL from the Tactical Outperform list as the potential catalyst for our call took place yesterday during their earnings print. AAPL reported Dec-qtr results of $117B/1.88 vs. street at $124B/1.95 with sales declining 5% y/y due to headwinds from f/x (~800bps), production... More
Gilead Sciences shares gain after topping expectations despite lower remdesivir sales
February 3, 2023 9:46 AM ESTGilead Sciences (NASDAQ: GILD) shares rallied in early Friday trading in reaction to the company's latest earnings report, which saw it beat top and bottom-line consensus expectations.
The biopharmaceutical company posted fourth-quarter earnings of $1.67 per share, $0.17 above the analyst consensus estimate of $1.50, while revenue for the quarter came in at $7.4 billion, beating expectations of $6.66 billion.
The company's revenue increased year-over-year, primarily due to increased sales in Oncology, HIV, and hepatitis C virus. However, this was partially offset by... More
Deutsche Bank Downgrades Ford (F) to Sell 'on operational shortfalls and earnings risk'
February 3, 2023 6:08 AM ESTDeutsche Bank analyst Emmanuel Rosner downgraded Ford (NYSE: F) from Hold to Sell with a price target of $11.00 (from $13.00).
The analyst comments "We are downgrading our Ford rating to Sell, following its large 4Q22 miss and new aggressive 2023 guidance, which in our view showcase considerable... More

